aStem-M-POF
Pre-clinical- Indications
- Premature ovarian failure
Company intelligence / Profile preview
Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.
Hainan Sheng, Chinapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. develops regenerative therapies based on human umbilical cord-derived mesenchymal stem cells. Their preclinical and early clinical studies have shown promising safety and efficacy in immune-mediated diseases such as ankylosing spondylitis, psoriasis, ischemic stroke, and liver cirrhosis. Clinical results indicate significant improvements in disease activity indices for ankylosing spondylitis with good tolerability profiles. The company’s technology leverages the immunomodulatory and regenerative properties of hUCMSCs prepared under GMP conditions.
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyImmunologyDermatology
- Modalities
- Mesenchymal stem cell therapy (hUCMSC; human umbilical cord mesenchymal stem cells)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborates closely with Shanghai Quansheng Biotechnology Co., Ltd. for manufacturing hUCMSCs under GMP conditions.Also associated with Zhejiang Quansheng Biotechnology Co., Ltd.
Beyond the preview
Go deeper on Asia Stem Cell Regenerative Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asia Stem Cell Regenerative Pharmaceutical Co., Ltd..